| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.13B | +14.5% |
| Cost of Revenue | $1.26B | -1.4% |
| Gross Profit | $867.8M | +15.6% |
| R&D Expense | $46.1M | -17.5% |
| SG&A Expense | $512.0M | -1.8% |
| Operating Income | $355.8M | +25.4% |
| Pre-tax Income | $338.5M | +26.8% |
| Income Tax | $70.3M | +11.2% |
| Net Income | $294.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $306.7M | -6.9% |
| Accounts Receivable | $339.1M | +10.7% |
| Inventory | $380.4M | +7.7% |
| Current Assets | $1.40B | +28.6% |
| Total Assets | $2.64B | +13.2% |
| Current Liabilities | $543.4M | +16.3% |
| Long-term Debt | $247.0M | -0.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $36.6M | -14.3% |
| Financing Cash Flow | -$49.7M | +88.3% |
| +15.2% |
| EPS (Basic) | $5.15 | +14.2% |
| EPS (Diluted) | $5.05 | +13.5% |
| Stockholders' Equity |
| $1.64B |
| +20.7% |